Indications & Uses
Nevalto 5/80 is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
As initial therapy and in patients not adequately controlled on valsartan 80 mg or nebivolol up to and including 10 mg, the recommended dose of 5 mg/80 mg (nebivolol/valsartan) is one tablet, taken orally once daily. Maximum antihypertensive effects are attained within 2 to 4 weeks. Increasing the dose of nebivolol/valsartan 5/80 does not result in any meaningful further blood pressure reduction. 5/80 may be substituted for its components in patients already receiving 5 mg nebivolol and 80 mg valsartan.
Side Effects
Hypotension Hyperkalemia
Cautions & Contraindications
Warnings & Precautions
Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue. Diabetes: Monitor glucose as -blockers may mask symptoms of hypoglycemia. In susceptible patients: Need to monitor renal function and potassium level.
Contraindications
This is contraindicated in the following conditions: Severe bradycardia Heart block greater than first degree Patients with cardiogenic shock Decompensated cardiac failure Sick sinus syndrome (unless a permanent pacemaker is in place) Patients with severe hepatic impairment (Child-Pugh >B) Patients who are hypersensitive to any component of this product Do not co-administer aliskiren with 5/80 in patients with diabetes